About Annexon Biosciences
Annexon Biosciences is a clinical-stage biopharmaceutical company pioneering novel therapies that inhibit C1q, the initiating molecule of the classical complement pathway. Their lead antibody candidates target Guillain-Barré syndrome, Huntington's disease, and geographic atrophy.
Careers & Hiring
No publicly listed openings right now
Check back later or visit Annexon Biosciences's careers portal for updates.
Similar Companies in Biotechnology
Explore verified active tech startups operating in the Biotechnology space.
30 Sundays
AI-native full-stack travel planning and itinerary booking engine
$6.7M · Series A
8090 Solutions
Sovereign AI code generation and legacy mainframe modernization for regulated industries
$135M · Series A
AbroBot AI
AI powered study abroad platform for university matching, SOP editing, scholarships, and visa guidance
$750K · Bootstrapped